Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting session of oropharyngeal cancer in association with HPV status of the patients. In this webinar, the speaker, Dr. Ashish M Kaushal, and Dr. Tejinder Singh has shared the important facts associated with head and neck cancer.
Oropharyngeal cancers are common in men as smoking is one of the primary reasons for having this disease. Also, being infected with human papillomavirus (HPV) can increase the risk of oropharyngeal cancer. Signs and symptoms of oropharyngeal cancer include a lump in the neck and a sore throat
HPV status is associated with the occurrence of cancer at the back of the throat, including the base of the tongue and tonsils. About 70% of oropharyngeal cancers occur in HPV positive individuals. However, HPV negative patients can also have head and neck cancers. Learn more about them through case studies in this session
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Providing essential cancer care to rural communities
2.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
3.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
4.
Treatment of Smoldering Myeloma Cuts Progression Rate in Half
5.
How Do Younger People Fare With Stool Tests for CRC Screening?
1.
Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being
2.
Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review
3.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
4.
The Truth About Marijuana and Its Effect on Mental Health
5.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation